Squarepoint Ops LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.02 - $7.48 $172,356 - $1.26 Million	168,977 New	168,977 $199,000
Q1 2021 May 17, 2021	SELL	$8.44 - $12.66 $467,483 - $701,224	-55,389 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$7.98 - $12.29 $332,271 - $511,731	41,638 Added 302.8%	55,389 $681,000
Q3 2020 Nov 16, 2020	BUY	$7.96 - $12.42 $109,457 - $170,787	13,751 New	13,751 $112,000
Q2 2020 Aug 14, 2020	SELL	$5.4 - $13.37 $225,255 - $557,716	-41,714 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$4.91 - $14.7 $410,014 - $1.23 Million	-83,506 Reduced 66.69%	41,714 $284,000
Q4 2019 Feb 14, 2020	BUY	$9.77 - $15.66 $77,866 - $124,810	7,970 Added 6.8%	125,220 $1.87 Million
Q3 2019 Nov 14, 2019	SELL	$9.59 - $12.0 $51,009 - $63,828	-5,319 Reduced 4.34%	117,250 $1.2 Million
Q2 2019 Aug 14, 2019	BUY	$9.54 - $14.96 $700,503 - $1.1 Million	73,428 Added 149.42%	122,569 $1.3 Million
Q1 2019 May 15, 2019	BUY	$10.31 - $14.38 $128,813 - $179,663	12,494 Added 34.09%	49,141 $687,000
Q4 2018 Feb 14, 2019	BUY	$8.63 - $12.4 $228,237 - $327,942	26,447 Added 259.28%	36,647 $372,000
Q3 2018 Nov 14, 2018	BUY	$9.6 - $12.9 $97,920 - $131,580	10,200 New	10,200 $122,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.